

Recent posts
- Allay on Cannabis Science and Technology: FDA Not Adopting Existing Regulations for the CBD Industry
- Allay Consulting’s March Newsletter: USDA Cracking Down on Organic Fraud
- Allay Consulting and The GMP Collective Combine Forces to Broaden Reach Across Cannabis, Hemp and Psychedelics
- Allay Consulting’s February Newsletter: FDA Will Not Use Existing Regulations for the CBD Industry
- Allay Consulting January Newsletter: Unpacking Recent Cannabis Emerging Markets